Teladoc Is Down 65%. Is It Time to Buy?
Teladoc Health (NYSE: TDOC) shares have been on a pretty consistent losing streak since the start of the year. And a recent goodwill impairment charge and headwinds for two of its key businesses added to the stock's woes. Teladoc now is down about 65% year to date.
At the same time, the telemedicine giant has continued to report double-digit revenue growth and increases in visits in an overall growth environment. At a compound annual growth rate of about 32%, the global telemedicine market is set to reach more than $636 billion by 2028, according to Fortune Business Insights. In such a situation, it's difficult to decide what to do. Should you forget about this healthcare stock? Or is now the best time to buy? Let's take a closer look.
Image source: Getty Images.
Source Fool.com
